Overview

Milk Patch for Eosinophilic Esophagitis

Status:
Completed

Trial end date:
2018-11-20

Target enrollment:

Participant gender:

Summary

This is a single-site, double-blind, placebo-controlled, randomized trial to study efficacy and safety of the Viaskin® Milk Patch for children with milk induced Eosinophilic Esophagitis (EoE). 20 subjects will be randomized 3:1 to Viaskin® Milk or placebo patch.

Phase:

Phase 2

Details

Lead Sponsor:

Children's Hospital of Philadelphia

Collaborator:

DBV Technologies

Treatments:

Immunologic Factors